多动儿童的药物治疗:苯哌啶醋酸甲酯的新剂型在法国上市

• 作 者: Le Heuzey M.-F. Vergnaud S. Mouren M.-C. 朱新菊
• 机 构: Service de Psych opathologie de l'Enfant et de l'Adolescent Hpital Robert-Debré 48 boule vard Séru
• 出 处: 世界核心医学期刊文摘(儿科学分册)
• 发表日期: 2006年05期
• 关键词: 哌啶 醋酸 药物治疗 剂型 渗透泵 哌甲酯 利他林 精神兴奋药 缓释剂型 缓释片

Multimodal treatment of hyperactive child includes psychostimulant medication, methylphenidate (MPH) marketed in France in its short-acting form since about ten years. We report our clinical experience about the first fifty methylphenida te responders who received one of the two sustained-release forms available since summer 2004, tablets of oros-methyphenidate (Concerta LP) or microgranule-f illed capsules (Ritaline LP).

Multimodal treatment of hyperactive child includes psychostimulant medication, methylphenidate (MPH) marketed in France in its short-acting form since about ten years. We report our clinical experience about the first fifty methylphenida te responders who received one of the two sustained-release forms available since summer 2004, tablets of oros-methyphenidate (Concerta LP) or microgranule-il il capsules (Ritaline LP).